✦ LIBER ✦

Phase I-II Study of Bendamustine in Patients With Acute Leukemia and High Risk Myelodysplastic Syndrome

✍ Scribed by Christelle Chacar; Elias Jabbour; Farhad Ravandi; Gautam Borthakur; Tapan Kadia; Zeev Estrov; Mary Beth Rios; Jorge Cortes; Hagop Kantarjian

Book ID: 119219034
Publisher: Elsevier
Year: 2012
Tongue: English
Weight: 207 KB
Volume: 12
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2012.03.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of sodium salicylate in pa

Phase I trial of sodium salicylate in patients with myelodysplastic syndromes and acute myelogenous leukemia

✍ Virginia M. Klimek; Emily K. Dolezal; Larry Smith; Gerald Soff; Stephen D. Nimer 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Intensive treatment strategies in patien

Intensive treatment strategies in patients with high-risk myelodysplastic syndrome and secondary acute myeloid leukemia

✍ M. Oosterveld; T. de Witte 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Phase I and II study of azacitidine in J

Phase I and II study of azacitidine in Japanese patients with myelodysplastic syndromes

✍ Toshiki Uchida; Yoshiaki Ogawa; Yukio Kobayashi; Takayuki Ishikawa; Haruhiko Oha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB

Predicting infections in high-risk patie

Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study

✍ Merkel, Drorit; Filanovsky, Kalman; Gafter-Gvili, Anat; Vidal, Liat; Aviv, Ariel 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

Predictors and outcome of acute kidney i

Predictors and outcome of acute kidney injury in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome

✍ Amit Lahoti; Hagop Kantarjian; Abdulla K. Salahudeen; Farhad Ravandi; Jorge E. C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

A Phase II Study of Lenalidomide Alone i

A Phase II Study of Lenalidomide Alone in Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes With Chromosome 5 Abnormalities

✍ Yiming Chen; Hagop Kantarjian; Zeev Estrov; Stefan Faderl; Farhad Ravandi; Krist 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 214 KB